Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- What are the hypersensitivity diseases?
- Type I hypersensitivity
- Lecture structure
- The key cells of allergy
- Allergens
- Evidence for the role of IgE in anaphylaxis
- Evidence for mast cell involvement
- Surface interactions of mast cells
- IgE and its receptors
- IgE cross-linking and mast cell degranulation
- Examples of mast cell products
- Mast cell products and their effects in tissues
- Main consequences of mediator release
- Examples of eosinophil secreted products
- Skin prick test for allergens
- Why does such an allergy prone system exist?
- Physiological basis of Tc2 (Th2) responses
- Cytokines that signal barrier epithelial damage
- Treatment and avoidance
- Thank you very much
Topics Covered
- Classes of hypersensitivity diseases
- Type I hypersensitivity disease
- Type I hypersensitivity mechanism of action
- Key cells involved in type I hypersensitivity
- Evolutionary and physiological basis for type I hypersensitivity disease
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Waldmann, H. (2021, June 30). Hypersensitivity diseases: type 1 hypersensitivity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 5, 2024, from https://doi.org/10.69645/PSRN6229.Export Citation (RIS)
Publication History
Financial Disclosures
- Herman Waldman has ownership interests in the Absolute Antibody company.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Herman Waldmann from the Department of Pathology in Oxford,
the Dunn School of Pathology,
and I'm going to give you a lecture on hypersensitivity diseases.
0:12
What are the hypersensitivity diseases?
These are adaptive immune responses to an antigen that instead of doing good,
result in damage to the host tissues.
You can think of them as an exaggeration of normal immune mechanisms,
and the antigens concerned can be either foreign antigens or indeed self-antigens.
When they're self-antigens, we think of them as autoimmune diseases.
Classically, the hypersensitivity diseases have been
classified by Gell and Coombs into four categories.
The first, type I, is caused by IgE,
one of the immunoglobulin classes,
and gives what's called immediate hypersensitivity.
That will be the topic of my lecture.
Type II hypersensitivity occurs when antibodies are targeted to cells,
and then cause them damage.
Really, there are variants of type II where the antibody
act as an agonist and binds to a receptor and stimulates that receptor.
For example, in hyperthyroidism in Graves disease,
this can be thought of as a type II or some people have referred to it as a type V.
In general, type II diseases are due to antibody binding,
either fixing complement, or attracting phagocytic cells with Fc receptor.
Type III hypersensitivity diseases are due to
antibody-antigen complexes that circulate and then deposit in tissues.
Finally, type IV hypersensitivity diseases are not caused by antibody
but caused by T cells that can target their antigen wherever it's located.
I'm going to focus on type I.